Skip to content

Fascia iliaca compartment block versus fascia iliaca compartment block combined with ilioinguinal-iliohypogastric nerve block for pain control after total hip replacement: a double-blind prospective trial

Fascia iliaca compartment block versus fascia iliaca compartment block combined with ilioinguinal-iliohypogastric nerve block for pain control after total hip replacement: a double-blind prospective trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031265
Enrollment
Unknown
Registered
2020-03-26
Start date
2020-04-05
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Closed hip fractures

Interventions

Compound low concentration group:Fascia iliaca compartment block was injected with low concentration ropivacaine + ilioinguinal-iliohypogastric nerve block was injected with low concentration ropivaca
compound high concentration group:Fascia iliaca compartment block was injected with high concentration ropivacaine + ilioinguinal-iliohypogastric nerve block was injected with high concentration ropiv
simple high concentration group:Fascia iliaca compartment block was injected with high concentration ropivacaine + ilioinguinal-iliohypogastric nerve block was injected with 0.9% NaCl

Sponsors

Funing People's Hospital of Jiangsu Province
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 90 patients with closed hip fracture underwent total hip replacement; 2. The age is 45-75 years old; 3. ASA grade I-II, body mass index (BMI) 20-29kg / ?. 4. Patients who are willing to sign informed consent must be able to understand and willing to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiopulmonary function and hepatorenal dysfunction; 2. Patients who are allergic to local anesthetics such as ropivacaine; 3. Patients with infection at the puncture site; 4. Patients with coagulation dysfunction; 5. Patients with mental disorders; 6. Patients with neuropathic pain or chronic pain; 7. Patients with other contraindications of nerve block; 8. Patients who refuse to perform regional block or cannot cooperate with pain assessment.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale/Score;

Countries

China

Contacts

Public ContactGuofa Shan

Funing People's Hospital of Jiangsu Province

278189607@qq.com+86 13605101785

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026